SGLT2 inhibition in CKD: Discussing the key questions & evidence
Meeting report with presentation slides and video of a PACE-CME symposium held during ISN-WCN 2019 in Melbourne on novel therapeutic approaches with SGLT2i & CKD (video will be posted soon)
1
Episodes 1-3 of 3
- SGLT2 inhibition in CKD: Discussing the key questions & evidenceThe known and unknown of SGLT2 inhibition in CKD
Carol Pollock, MD
- SGLT2 inhibition in CKD: Discussing the key questions & evidenceOutcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?
Mark Cooper, MD
- SGLT2 inhibition in CKD: Discussing the key questions & evidenceThe clinical landscape of managing patients with CKD
Prof. David Cherney
